StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CODX

Co-Diagnostics, Inc.

CODX Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$1.48
-0.08 -5.13%

Key statistics

from XBRL data in SEC filings
Market cap
$5.33M
Revenue (TTM)
$718K
Net income (TTM)
-$48.6M
EPS (TTM)
$-32.26
P/E ratio
Dividend yield
Free cash flow
-$29.8M
Cash
$8.23M
Total assets
$21.5M
Gross margin
45.1%
52-week range
$1.26 – $46.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Unregistered sale of equity Jul 31, 2026 8-K Entered a material agreement Jul 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2026 8-K Results of operations (earnings release); Other events Mar 10, 2026 8-K Delisting notice or listing-rule failure Jan 13, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Dec 30, 2025 8-K Shareholder vote results Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 8-K Entered a material agreement; Other events Oct 29, 2025 8-K Entered a material agreement; Terminated a material agreement Oct 20, 2025 8-K Regulation FD disclosure Sep 30, 2025 8-K Entered a material agreement; Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K Other events Jul 11, 2025 8-K Shareholder vote results May 29, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 8-K Entered a material agreement; Other events Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 8-K Other events Feb 21, 2025 8-K Delisting notice or listing-rule failure Jan 10, 2025 8-K/A Shareholder vote results Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Shareholder vote results Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Other events Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 8-K Director or officer change Mar 15, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 14, 2024